Article info
PDFOriginal article
Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis
- Correspondence to Dr Hedyeh Shafi, Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Room 8709, Los Angeles, CA 90048, USA; hedyeh.shafi{at}cshs.org
Citation
Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis
Publication history
- Received December 17, 2012
- Revised March 5, 2013
- Accepted March 6, 2013
- First published March 28, 2013.
Online issue publication
July 22, 2013
Article Versions
- Previous version (28 March 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions